Combating multidrug-resistance in S. pneumoniae : a G-quadruplex binding inhibitor of efflux pump and its bio-orthogonal assembly
NAR Molecular Medicine · 2024
DOI: 10.1093/narmme/ugae005 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Molecular Medicine, 2024. Verfasst von Ritapa Chaudhuri und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Sciences, Indian Association for the Cultivation of Science, Kolkata, West-Bengal 700032, India. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust, DBT Alliance, India, Science and Engineering Research Board.
Abstract (Originalsprache)
Antibiotic resistance poses a significant global health threat, necessitating innovative strategies to combat multidrug-resistant bacterial infections. Streptococcus pneumoniae, a pathogen responsible for various infections, harbors highly conserved DNA quadruplexes in genes linked to its pathogenesis. In this study, we introduce a novel approach to counter antibiotic resistance by stabilizing G-quadruplex structures within the open reading frames of key resistance-associated genes (pmrA, recD and hsdS). We synthesized An4, a bis-anthracene derivative, using Cu(I)-catalyzed azide-alkyne cycloaddition, which exhibited remarkable binding and stabilization of the G-quadruplex in the pmrA gene responsible for drug efflux. An4 effectively permeated multidrug-resistant S. pneumoniae strains, leading to a substantial 12.5-fold reduction in ciprofloxacin resistance. Furthermore, An4 downregulated pmrA gene expression, enhancing drug retention within bacterial cells. Remarkably, the pmrA G-quadruplex cloned into the pET28a(+) plasmid transformed into Escherichia coli BL21 cells can template Cu-free bio-orthogonal synthesis of An4 from its corresponding alkyne and azide fragments. This study presents a pioneering strategy to combat antibiotic resistance by genetically reducing drug efflux pump expression through G-quadruplex stabilization, offering promising avenues for addressing antibiotic resistance.
Autor:innen und Institutionen
- School of Chemical Sciences, Indian Association for the Cultivation of Science, Kolkata, West-Bengal 700032, India.
- Laboratory Medicine, Chittaranjan National Cancer Institute, Kolkata, West Bengal 700156, India.
ORCID-Profile: Jyotirmayee Dash
Förderung
- Wellcome Trust
- DBT Alliance, India
- Science and Engineering Research Board
Zitieren
APA
Chaudhuri, R., Prasanth, T., Biswas, D., Mandal, S., & Dash, J. (2024). Combating multidrug-resistance in S. pneumoniae : a G-quadruplex binding inhibitor of efflux pump and its bio-orthogonal assembly. NAR Molecular Medicine. https://doi.org/10.1093/narmme/ugae005
Vancouver
Chaudhuri R, Prasanth T, Biswas D, Mandal S, Dash J. Combating multidrug-resistance in S. pneumoniae : a G-quadruplex binding inhibitor of efflux pump and its bio-orthogonal assembly. NAR Molecular Medicine. 2024. doi:10.1093/narmme/ugae005
BibTeX
@article{Chaudhuri2024,
author = {Chaudhuri, Ritapa and Prasanth, Thumpati and Biswas, Debasmita and Mandal, Subhranshu and Dash, Jyotirmayee},
title = {Combating multidrug-resistance in S. pneumoniae : a G-quadruplex binding inhibitor of efflux pump and its bio-orthogonal assembly},
journal = {NAR Molecular Medicine},
year = {2024},
doi = {10.1093/narmme/ugae005}
}
EUVIMED